Company · CIK 1419041
Forte Biosciences, Inc.
| CIK | 1419041 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | TX |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2017-05-23 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-224880 | 2018-05-11 | 2026-09-01 | 10 | |
| 333-256611 | 2021-05-28 | 2026-09-01 | 5 | |
| 333-274257 | 2023-08-29 | 2026-09-01 | 3 | |
| 333-283814 | 2024-12-13 | 2026-09-01 | 3 | |
| 333-286226 | 2025-03-28 | 2026-09-01 | 7 | |
| 333-296425 | 2026-06-02 | 2026-09-01 | 3 | |
| 333-216574 | 2017-03-09 | 2017-04-13 | 4 |
Filings
37| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-01 | EFFECTDeclared effective | 333-296425 | 9999999995-26-002850 |
| 2026-09-01 | EFFECTDeclared effective | 333-286226 | 9999999995-26-002848 |
| 2026-09-01 | EFFECTDeclared effective | 333-283814 | 9999999995-26-002847 |
| 2026-09-01 | EFFECTDeclared effective | 333-274257 | 9999999995-26-002846 |
| 2026-09-01 | EFFECTDeclared effective | 333-256611 | 9999999995-26-002844 |
| 2026-09-01 | EFFECTDeclared effective | 333-224880 | 9999999995-26-002843 |
| 2026-06-10 | EFFECTDeclared effective | 333-296425 | 9999999995-26-001951 |
| 2026-06-02 | S-3Shelf registered | 333-296425 | 0001193125-26-253668 |
| 2026-04-09 | 424B5Shelf takedown | 333-286226 | 0001193125-26-149630 |
| 2026-04-08 | 424B5Shelf takedown | 333-286226 | 0001193125-26-147698 |
| 2025-06-25 | 424B5Shelf takedown | 333-286226 | 0001193125-25-147053 |
| 2025-06-24 | 424B5Shelf takedown | 333-286226 | 0001193125-25-145774 |
| 2025-04-03 | EFFECTDeclared effective | 333-286226 | 9999999995-25-000978 |
| 2025-03-28 | S-3Shelf registered | 333-286226 | 0001193125-25-067182 |
| 2024-12-20 | EFFECTDeclared effective | 333-283814 | 9999999995-24-003905 |
| 2024-12-13 | S-3Shelf registered | 333-283814 | 0001193125-24-278627 |
| 2023-09-08 | EFFECTDeclared effective | 333-274257 | 9999999995-23-002612 |
| 2023-08-29 | S-3Shelf registered | 333-274257 | 0001193125-23-223992 |
| 2022-08-12 | 424B5Shelf takedown | 333-256611 | 0001193125-22-220037 |
| 2022-04-01 | 424B5Shelf takedown | 333-256611 | 0001193125-22-092355 |
| 2021-06-07 | EFFECTDeclared effective | 333-256611 | 9999999995-21-002244 |
| 2021-05-28 | S-3Shelf registered | 333-256611 | 0001193125-21-176915 |
| 2020-10-29 | 424B5Shelf takedown | 333-224880 | 0001193125-20-281202 |
| 2020-10-28 | 424B5Shelf takedown | 333-224880 | 0001193125-20-280017 |
| 2020-10-28 | 424B5Shelf takedown | 333-224880 | 0001193125-20-279878 |
| 2020-09-04 | 424B5Shelf takedown | 333-224880 | 0001193125-20-240152 |
| 2020-05-13 | EFFECTDeclared effective | 333-237371 | 9999999995-20-001141 |
| 2018-12-13 | 424B5Shelf takedown | 333-224880 | 0001193125-18-348834 |
| 2018-12-12 | 424B5Shelf takedown | 333-224880 | 0001193125-18-347276 |
| 2018-11-21 | 424B5Shelf takedown | 333-224880 | 0001193125-18-332427 |
| 2018-05-23 | EFFECTDeclared effective | 333-224880 | 9999999995-18-001324 |
| 2018-05-11 | S-3Shelf registered | 333-224880 | 0000950123-18-004952 |
| 2017-04-13 | 424B4Final prospectus | 333-216574 | 0001193125-17-123405 |
| 2017-04-12 | EFFECTDeclared effective | 333-216574 | 9999999995-17-000800 |
| 2017-04-03 | S-1/AAmendment | 333-216574 | 0001193125-17-107559 |
| 2017-03-09 | S-1Registration filed | 333-216574 | 0001193125-17-077001 |
| 2015-10-23 | DRSDraft made public | 377-01186 | 0000950123-15-010448 |